Alerts
Holiday Hours Information

In recognition of the Christmas and New Year’s holidays, some of The University of Kansas Cancer Center’s offices will have modified hours on Wednesday, December 25, and Wednesday, January 1.

Skip Navigation

Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer after Radical Prostatectomy INNOVATE INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT04134260

Study #:
STUDY00145515

Start Date:
Apr 30, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04134260

View Complete Trial Details & Eligibility at ClinicalTrials.gov